Product: diazePAM 5 MG/ML INJECTION SOLUTION (C-IV) SYR, 2 ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701.  NDC: 70731-0929-02
Reason for recall: Lack of Assurance of Sterility
Recall initiated: 20190619
Status: Terminated
Classification: Class II
Recall type: Voluntary: Firm initiated